An advisory committee to the US Center for Disease Control and Prevention (CDC) is scheduled to vote Tuesday afternoon on the priority designation of COVID-19 vaccines, as the US Food and Drug Administration (FDA) receives two vaccines each month for emergencies Prepares to review candidates Use authorization.
The meeting on Tuesday will meet the priorities of the vaccine administration, which is expected to put health care workers and nursing home staff and residents at the top of the list. But some experts also say that vaccinating minority communities, which adversely affect coronoviruses, should also be a priority.
How delivery will work locally and whether there will be sufficient doses to vaccinate health care workers and the elderly, however, remains to be seen.
Dr., an emergency physician at Naval Medical Center Portsmouth. Joshua Lesko wrote on Monday, “The anticipated (40 million) doses … are not enough to cover even these two groups.”
The pair are expected to receive a dose from Modern (MRNA) and Pfizer (PFE) and BioNTech (BNTX), which have been filed for the Emergency Use Authority.
But the CDC’s vote focuses on the first group dubbed in the first phase on Tuesday, which may include only health workers, as the previous meetings commented.
The need for a vaccine for health workers has increased in recent weeks, as the country anticipates even more pressure on hospitals and healthcare facilities after Thanksgiving. Hospitals have already increased overall, with daily numbers decreasing slightly due to strict thresholds for accepting patients. As of Tuesday, about 100,000 individuals were hospitalized.
Experts are also focusing on the upcoming administration change, as President-Elect will be in Joe Biden’s post, when most vaccines are delivered.
An emergency doctor Jeremy Faust said, “It makes sense for the Biden Kovid-19 advisory board to be involved in these decisions, but I suspect that the level of cooperation is being given by the outgoing administration – which is unfortunate.” Brigham and Women’s Hospital in Boston.
Meanwhile, as President Donald Trump faces the end of his administration, what will become of Operation Taunt momentum and its top officials remain a question. But the White House Coronavirus Advisor, Drs. Scott Atlas, Resigned on monday.
The resignation of the controversial advisor, who was disqualified for the position by some, is likely to bring relief for members of the White House COVID-19 task force. Director of the National Institute of Allergy and Infectious Diseases, Drs. Anthony Fauci has stated that he disagrees with Atlas and his views several times.
Most notably, Atlas pushed the idea of herd immunity, which allows Americans to get sick and avoid mitigation tactics to promote more natural immunity to the virus.
Dean of Brown University’s School of Public Health, Drs. Ashish Jha Said on twitter“How badly some people are responsible as Scott. His tenure on federal pay is really terrible.
Jha said Atlas spread inaccurate data and made several inaccurate claims about the virus, as he had “found a buyer” in Trump. Atlas, however, said that it relies on statistics and has the support of experts from top institutions.
“I always relied on the latest science and evidence … These ideas were in agreement with many of the world’s top epidemiologists and medical scientists,” Atlas said. “I can’t think of a time where protecting science and scientific debate is more important.”
Read the latest financial and business news from Yahoo Finance
Follow yahoo finance Twitter, Facebook, Instagram, Flipboard, SmartNews, Linkedin, Youtube.